473 related articles for article (PubMed ID: 23451962)
1. An update of consensus guidelines for warfarin reversal.
Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
[TBL] [Abstract][Full Text] [Related]
2. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.
Baker RI; Coughlin PB; Gallus AS; Harper PL; Salem HH; Wood EM;
Med J Aust; 2004 Nov; 181(9):492-7. PubMed ID: 15516194
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic interventions for reversing the effects of oral anticoagulants.
Kalus JS
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
[TBL] [Abstract][Full Text] [Related]
4. Developing a management plan for oral anticoagulant reversal.
Dager WE
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
[TBL] [Abstract][Full Text] [Related]
5. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.
Tran H; Collecutt M; Whitehead S; Salem HH
Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070
[TBL] [Abstract][Full Text] [Related]
7. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
Fan J; Armitstead JA; Adams AG; Davis GA
Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
[TBL] [Abstract][Full Text] [Related]
8. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
9. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
10. Warfarin reversal: an audit of prescribing practices at Capital and Coast District Health Board.
Jolliffe E; Flanagan P
N Z Med J; 2014 Sep; 127(1403):32-40. PubMed ID: 25290497
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
Zhang H; Li M; Ao XL; Dong YJ; Dong L
Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
[TBL] [Abstract][Full Text] [Related]
12. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
Bian C; Qi X; Li L; Zhao J; Liu X
Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
[TBL] [Abstract][Full Text] [Related]
14. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
15. Prothrombinex-VF use in warfarin reversal and other indications.
Kruger PC; Le Viellez AS; Herrmann RP
Med J Aust; 2012 Apr; 196(7):462-5. PubMed ID: 22509878
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis.
Chai-Adisaksopha C; Hillis C; Siegal DM; Movilla R; Heddle N; Iorio A; Crowther M
Thromb Haemost; 2016 Oct; 116(5):879-890. PubMed ID: 27488143
[TBL] [Abstract][Full Text] [Related]
17. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
18. PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
Bobbitt L; Merriman E; Raynes J; Henderson R; Blacklock H; Chunilal S
Thromb Res; 2011 Dec; 128(6):577-82. PubMed ID: 21621251
[TBL] [Abstract][Full Text] [Related]
19. [Hemorrhagic complications during warfarin treatment].
Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
